Distribution of Starry Pharmaceutical's revenue in 2022, by region
In 2022, the Chinese pharmaceutical firm Starry Pharmaceutical gained revenue of around 1.2 billion yuan from the domestic market. Although a relatively small company in the industry, Starry is one of the most important manufacturers of radiocontrast agents in China.